AsortinoBeta
Regeneron Pharmaceuticals, Inc. logo

REGNRegeneron Pharmaceuticals, Inc.

NASDAQStockHealthcareBiotechnology🇺🇸 United StatesISIN US75886F1075regeneron.com
$827.721.87%
NASDAQ · at close Sep 4, 2026
Tokenized by
Ondo Finance logoBacked Finance logoReality logoDinari Inc. logo
4 issuersOn
BNB Chain logoEthereum logoSolana logoXLayer logo
14 chains

Chart data are delayed by 15 minutes.

1D1.87%
1M+8.82%
3M+31.65%
1Y+45.93%
3Y0.47%
5Y+21.80%

Main metrics

$85.22B
$12.74K<0.01% of mkt cap
20.49
$40.39
0.45%
757.5K
0.19
$541.0052-week range$859.34

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, develops, manufactures, and commercializes medicines for people with serious diseases. Its portfolio spans treatments in eye care, immunology, oncology, cardiovascular and metabolic disease, infectious disease, hematology, and rare disorders. The company is known for combining laboratory research, clinical development, and in-house manufacturing to advance biologic therapies and antibody-based medicines. Regeneron also works on product candidates across multiple therapeutic areas, supporting a broad drug pipeline alongside its marketed medicines. Regeneron Pharmaceuticals, Inc. plays an important role in the healthcare market through its focus on specialty therapies designed for complex and often chronic medical conditions.

Similar products

Alnylam Pharmaceuticals, Inc. logo
ALNYNASDAQ
$266.11+0.61%
Alnylam Pharmaceuticals, Inc.
Backed Finance logoReality logo
2 issuers · 10 chains
Arrowhead Pharmaceuticals, Inc. logo
ARWRNASDAQ
$86.340.17%
Arrowhead Pharmaceuticals, Inc.
Reality logo
1 issuer · 2 chains
Axsome Therapeutics Inc. logo
AXSMNASDAQ
$206.680.80%
Axsome Therapeutics Inc.
Reality logo
1 issuer · 2 chains
BridgeBio Pharma Inc. logo
BBIONASDAQ
$74.840.76%
BridgeBio Pharma Inc.
Reality logo
1 issuer · 2 chains